Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Quantitative trait loci controlling light and hormone response in two accessions of Arabidopsis thaliana.
Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A.
Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations.
p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas.
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol. 2005 Nov 01; 23(31):8033-40.
View in:
PubMed
subject areas
Adenocarcinoma
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Deoxycytidine
Disease Progression
Disease-Free Survival
Female
Humans
Liver Neoplasms
Lung Neoplasms
Male
Middle Aged
Pancreatic Neoplasms
Peritoneal Neoplasms
Survival Rate
Treatment Outcome
Vascular Endothelial Growth Factor A
authors with profiles
Hedy Kindler
Mark Kozloff
Abraham H. Dachman
Walter M. Stadler
Everett E. Vokes
Theodore Karrison